PhaseBio Pharmaceuticals, Inc. (PHAS)
Interest Expense
$1.25M
TTM · Period ending: · USD
PHAS Interest Expense
Latest reported$1.25Mperiod ending
Latest reported$1.25Mperiod ending
PHAS TTM Interest Expense ($4.59M → $1.25M)
TTM interest expense
High-resolution chart · PNG
PHAS interest expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Interest Expense (USD) |
|---|---|
| 1,247,947 | |
| 1,385,947 | |
| 1,522,947 | |
| 1,087,000 | |
| 1,227,000 | |
| 1,352,000 | |
| 1,445,000 | |
| 1,484,000 | |
| 1,388,000 | |
| 1,228,000 | |
| 1,076,000 | |
| 894,000 | |
| 1,518,000 | |
| 2,746,000 | |
| 3,924,000 | |
| 4,859,000 | |
| 4,587,000 |